Home

News

Partnership to support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.

New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

14 Jul 2021
Press release

Study run in partnership with the CANTAM network and published in PLoS Medicine supports further uptake of antimalarial in Africa.

Pyronaridine-artesunate demonstrates high real-life safety, tolerability and effectiveness in the treatment of uncomplicated malaria in large multi-country study in Africa

17 Jun 2021
Press release

Trends in Parasitology publishes MMV’s new strategy to assess risk of resistance early in preclinical development.

MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development

31 May 2021
News story

Statement delivered at 74th World Health Assembly.

MMV and DNDi urge WHO member states to invest in medicines for women and children

27 May 2021
News story
View all news